阿片类药物使用对全髋关节置换术后血栓栓塞并发症、再入院率及90天诊疗费用的影响
本研究基于全国数据库,将全髋关节置换术前90天内有阿片类药物使用障碍(OUD)的患者按1:5匹配对照,比较术后90天静脉血栓栓塞、再入院率及诊疗费用。结果显示OUD患者血栓栓塞风险、再入院风险及费用均显著高于非OUD患者。
要点
- OUD患者术后90天静脉血栓栓塞风险显著升高(2.38% vs 1.07%,OR 2.25)。
- OUD患者90天再入院风险增加(28.68% vs 22.62%,OR 1.37)。
- OUD患者90天诊疗费用更高($20,610.65 vs $17,964.58,高14.72%)。
核心结论
- 有OUD病史的原发性全髋关节置换患者术后90天内血栓栓塞并发症、再入院及诊疗费用风险均更高。
研究设计与样本
- 回顾性队列研究,从全国数据库识别THA术前90天内有OUD病史的患者,按年龄、性别、Elixhauser共病指数评分及高危内科共病1:5匹配对照,共纳入38,821例(OUD 6,398例,非OUD 31,883例)。
主要发现
- OUD患者90天静脉血栓栓塞发生率为2.38%,非OUD为1.07%(OR 2.25,95%CI 1.86-2.73,P<.0001)。
- OUD患者深静脉血栓发生率为2.13%,非OUD为0.87%(OR 2.46,95%CI 2.00-3.03,P<.001)。
- OUD患者肺栓塞发生率为0.61%,非OUD为0.27%(OR 2.24,95%CI 1.53-3.27,P<.0001)。
- OUD患者90天再入院率为28.68%,非OUD为22.62%(OR 1.37,95%CI 1.29-1.46,P<.0001)。
- OUD患者90天诊疗费用为$20,610.65,非OUD为$17,964.58,OUD患者费用高14.72%。
临床怎么用
- 对计划行全髋关节置换的患者,术前应识别90天内OUD病史以评估血栓栓塞和再入院风险。
- 对OUD患者可考虑加强围手术期血栓预防及出院后随访,以降低再入院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to investigate whether opioid use disorder (OUD) patients are at greater odds than non-opioid use disorder (NUD) patients in developing (1) thromboembolic complications; (2) readmission rates; and (3) costs of care. METHODS: All patients with a 90-day history of OUD before total hip arthroplasty (THA) were identified from a national database. Patients were matched 1:5 to controls by age, gender, Elixhauser Comorbidity Index scores, and high-risk medical comorbidities, yielding 38,821 patients with (n = 6398) and without (n = 31,883) OUD. Multivariate logistic regression analyses were performed to compare the risks of developing venous thromboembolism (deep vein thrombosis and/or pulmonary embolism) 90 days after the index procedure, 90-day readmission rates, and total global 90-day episode of care costs. RESULTS: Patients with a history of OUD were found to be at greater risk for 90-day venous thromboembolisms (2.38 vs. 1.07%; OR: 2.25, 95% CI: 1.86-2.73, P < .0001) compared with matched NUD patients. Specifically, OUD patients were at greater risk for both deep vein thromboses (2.13 vs. 0.87%; OR: 2.46, 95% CI: 2.00-3.03, P < .001) and pulmonary embolism (0.61 vs. 0.27%; OR: 2.24, 95% CI: 1.53-3.27, P < .0001). In addition, patients with OUD were at an increased risk for 90-day readmission (28.68 vs. 22.62%; OR: 1.37, 95% CI: 1.29-1.46, P < .0001) compared with controls. Primary THA patients with OUD incurred a 14.72% higher cost of care ($20,610.65 vs. $17,964.58) compared with NUD patients. CONCLUSION: These findings demonstrate that primary THA patients with a history of OUD are at greater risks for thromboembolic complications, readmissions, and higher costs of care in the 90-day postoperative period.
引用
- Sodhi N, Anis HK, Acuña AJ, et al. The Effects of Opioid Use on Thromboembolic Complications, Readmission Rates, and 90-Day Episode of Care Costs After Total Hip Arthroplasty. J Arthroplasty. 2020. PMID: 32197965. doi:10.1016/j.arth.2020.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。